-
Je něco špatně v tomto záznamu ?
Apical versus Non-Apical Lead: Is ICD Lead Position Important for Successful Defibrillation
G. Amit, J. Wang, SJ. Connolly, M. Glikson, S. Hohnloser, DJ. Wright, J. Brachmann, P. Defaye, J. Neuzner, P. Mabo, L. Vanerven, X. Vinolas, G. O'Hara, J. Kautzner, U. Appl, F. Gadler, K. Stein, Y. Konstantino, JS. Healey,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie, randomizované kontrolované studie, práce podpořená grantem
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 1990-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1990-02-01 do Před 1 rokem
PubMed
26888558
DOI
10.1111/jce.12952
Knihovny.cz E-zdroje
- MeSH
- časové faktory MeSH
- defibrilátory implantabilní * MeSH
- elektrická defibrilace škodlivé účinky přístrojové vybavení metody mortalita MeSH
- elektrofyziologické techniky kardiologické MeSH
- Kaplanův-Meierův odhad MeSH
- kardiostimulace umělá MeSH
- lidé středního věku MeSH
- lidé MeSH
- logistické modely MeSH
- náhlá srdeční smrt etiologie MeSH
- proporcionální rizikové modely MeSH
- prospektivní studie MeSH
- protézy - design MeSH
- rizikové faktory MeSH
- selhání protézy MeSH
- senioři MeSH
- srdeční arytmie komplikace diagnóza mortalita terapie MeSH
- tendenční skóre MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
INTRODUCTION: We aim to compare the acute and long-term success of defibrillation between non-apical and apical ICD lead position. METHODS AND RESULTS: The position of the ventricular lead was recorded by the implanting physician for 2,475 of 2,500 subjects in the Shockless IMPLant Evaluation (SIMPLE) trial, and subjects were grouped accordingly as non-apical or apical. The success of intra-operative defibrillation testing and of subsequent clinical shocks were compared. Propensity scoring was used to adjust for the impact of differences in baseline variables between these groups. There were 541 leads that were implanted at a non-apical position (21.9%). Patients implanted with a non-apical lead had a higher rate of secondary prevention indication. Non-apical location resulted in a lower mean R-wave amplitude (14.0 vs. 15.2, P < 0.001), lower mean pacing impedance (662 ohm vs. 728 ohm, P < 0.001), and higher mean pacing threshold (0.70 V vs. 0.66 V, P = 0.01). Single-coil leads and cardiac resynchronization devices were used more often in non-apical implants. The success of intra-operative defibrillation was similar between propensity score matched groups (89%). Over a mean follow-up of 3 years, there were no significant differences in the yearly rates of appropriate shock (5.5% vs. 5.4%, P = 0.98), failed appropriate first shock (0.9% vs. 1.0%, P = 0.66), or the composite of failed shock or arrhythmic death (2.8% vs. 2.3% P = 0.35) according to lead location. CONCLUSION: We did not detect any reduction in the ICD efficacy at the time of implant or during follow-up in patients receiving a non-apical RV lead.
Boston Scientific Minneapolis Minnesota USA Boston Scientific Brussels Belgium
Centre Hospitalier Universitaire Rennes France
CHU Hopital Michallon Grenoble France
Hospital de Santa Creu i Sant Pau Barcelona Spain
Institut Universitaire de Cardiologie et de Pneumologie de Québec Québec Canada
Institute for Clinical and Experimental Medicine Prague Czech Republic
J W Goethe University Frankfurt Germany
Karolinska Institute Stockholm Sweden
Klinikum Coburg GbmH Coburg Germany
Klinikum Kassel Kassel Germany
Leiden University Medical Center Leiden the Netherlands
Leviev Heart Center Sheba Medical Center Tel Hashomer Israel
Liverpool Heart and Chest Hospital Liverpool UK
Soroka Medical Center Ben Gurion University Beer Sheva Israel
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017352
- 003
- CZ-PrNML
- 005
- 20180518095201.0
- 007
- ta
- 008
- 180515s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jce.12952 $2 doi
- 035 __
- $a (PubMed)26888558
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Amit, Guy $u Hamilton Health Sciences, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
- 245 10
- $a Apical versus Non-Apical Lead: Is ICD Lead Position Important for Successful Defibrillation / $c G. Amit, J. Wang, SJ. Connolly, M. Glikson, S. Hohnloser, DJ. Wright, J. Brachmann, P. Defaye, J. Neuzner, P. Mabo, L. Vanerven, X. Vinolas, G. O'Hara, J. Kautzner, U. Appl, F. Gadler, K. Stein, Y. Konstantino, JS. Healey,
- 520 9_
- $a INTRODUCTION: We aim to compare the acute and long-term success of defibrillation between non-apical and apical ICD lead position. METHODS AND RESULTS: The position of the ventricular lead was recorded by the implanting physician for 2,475 of 2,500 subjects in the Shockless IMPLant Evaluation (SIMPLE) trial, and subjects were grouped accordingly as non-apical or apical. The success of intra-operative defibrillation testing and of subsequent clinical shocks were compared. Propensity scoring was used to adjust for the impact of differences in baseline variables between these groups. There were 541 leads that were implanted at a non-apical position (21.9%). Patients implanted with a non-apical lead had a higher rate of secondary prevention indication. Non-apical location resulted in a lower mean R-wave amplitude (14.0 vs. 15.2, P < 0.001), lower mean pacing impedance (662 ohm vs. 728 ohm, P < 0.001), and higher mean pacing threshold (0.70 V vs. 0.66 V, P = 0.01). Single-coil leads and cardiac resynchronization devices were used more often in non-apical implants. The success of intra-operative defibrillation was similar between propensity score matched groups (89%). Over a mean follow-up of 3 years, there were no significant differences in the yearly rates of appropriate shock (5.5% vs. 5.4%, P = 0.98), failed appropriate first shock (0.9% vs. 1.0%, P = 0.66), or the composite of failed shock or arrhythmic death (2.8% vs. 2.3% P = 0.35) according to lead location. CONCLUSION: We did not detect any reduction in the ICD efficacy at the time of implant or during follow-up in patients receiving a non-apical RV lead.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a srdeční arytmie $x komplikace $x diagnóza $x mortalita $x terapie $7 D001145
- 650 _2
- $a kardiostimulace umělá $7 D002304
- 650 _2
- $a náhlá srdeční smrt $x etiologie $7 D016757
- 650 12
- $a defibrilátory implantabilní $7 D017147
- 650 _2
- $a elektrická defibrilace $x škodlivé účinky $x přístrojové vybavení $x metody $x mortalita $7 D004554
- 650 _2
- $a elektrofyziologické techniky kardiologické $7 D022062
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a logistické modely $7 D016015
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a tendenční skóre $7 D057216
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a protézy - design $7 D011474
- 650 _2
- $a selhání protézy $7 D011475
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Wang, Jia $u Hamilton Health Sciences, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Connolly, Stuart J $u Hamilton Health Sciences, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Glikson, Michael $u Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.
- 700 1_
- $a Hohnloser, Stephan $u J.W. Goethe University, Frankfurt, Germany.
- 700 1_
- $a Wright, David J $u Liverpool Heart and Chest Hospital, Liverpool, UK.
- 700 1_
- $a Brachmann, Johannes $u Klinikum Coburg GbmH, Coburg, Germany.
- 700 1_
- $a Defaye, Pascal $u CHU Hopital Michallon, Grenoble, France.
- 700 1_
- $a Neuzner, Joerg $u Klinikum Kassel, Kassel, Germany.
- 700 1_
- $a Mabo, Philippe $u Centre Hospitalier Universitaire, Rennes, France.
- 700 1_
- $a Vanerven, Liselot $u Leiden University Medical Center, Leiden, the Netherlands.
- 700 1_
- $a Vinolas, Xavier $u Hospital de Santa Creu i Sant Pau, Barcelona, Spain.
- 700 1_
- $a O'Hara, Gilles $u Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada.
- 700 1_
- $a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Appl, Ursula $u Boston Scientific, Minneapolis, Minnesota, USA. Boston Scientific, Brussels, Belgium.
- 700 1_
- $a Gadler, Fredrik $u Karolinska Institute, Stockholm, Sweden.
- 700 1_
- $a Stein, Kenneth $u Boston Scientific, Minneapolis, Minnesota, USA. Boston Scientific, Brussels, Belgium.
- 700 1_
- $a Konstantino, Yuval $u Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel.
- 700 1_
- $a Healey, Jeff S $u Hamilton Health Sciences, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
- 773 0_
- $w MED00002569 $t Journal of cardiovascular electrophysiology $x 1540-8167 $g Roč. 27, č. 5 (2016), s. 581-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26888558 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180518095338 $b ABA008
- 999 __
- $a ok $b bmc $g 1300976 $s 1014192
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 27 $c 5 $d 581-6 $e 20160405 $i 1540-8167 $m Journal of cardiovascular electrophysiology $n J Cardiovasc Electrophysiol $x MED00002569
- LZP __
- $a Pubmed-20180515